CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 24 enrolled
Drug / intervention
2 Gums +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02610270
NCT02610270Early Ph 1Completed
CompareCT.gov

Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response

Centre d'Alt Rendiment·interventional·Posted Nov 20, 2015·Updated Nov 20, 2015

In Brief

A Early Phase 1 clinical trial evaluating 2 Gums and 3 Gums for Healthy. Completed, enrolled 24 participants.

Detailed Summary

A suitable concentration of omega-3 fatty acids in relation to omega 6 is considered necessary for a good cell function and prevention of various inflammatory processes. Diet and supplementation are the fundamental procedures to achieve the reference values for several years. Athletes are individuals under physical stress and higher tissue restoration, while maintaining adequate diets they show, as the rest of humans, lower than desired levels. In the present study the investigators aims to determine the modification of those levels by the administration of two different doses of a given product, keeping the same model of diet and physical and competition.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--

Timeline

Early Ph 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 20, 2015
Enrollment StartJun 1, 2014
Primary CompletionJan 1, 2015
Study CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.6 years ago

Interventions

2 Gumsdietary

760 mg DHA

3 Gumsdietary

1140 mg DHA